

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
Pertuzumab ni umuti w'indwara ya kanseri ugamije gufasha kurwanya ubwoko runaka bwa kanseri y'ibere. Ni ubwoko bw'umuti w'ubudahangarwa ukora ubugizi bwa nabi buhagarika poroteyine zihariye zifasha selile za kanseri gukura no gukwirakwira.
Uyu muti uhora utangwa binyuze mu muyoboro wa IV (intravenous) mu bitaro cyangwa mu ivuriro. Ntabwo uzigera ufata uyu muti uri mu rugo, kuko bisaba ubugenzuzi bw'abaganga n'ubugenzuzi bwitondewe mu gihe cyose cyo kuvurwa.
Pertuzumab ni umuti wa monoclonal antibody wagenewe kwibasira kanseri y'ibere ya HER2-positive. Tekereza nk'urufunguzo rworoshye cyane rufunga kuri poroteyine zimwe na zimwe kuri selile za kanseri, zikazibuza gukura.
Uyu muti ni uwo mu cyiciro cy'imiti yitwa HER2 antagonists. Yakozwe muri laboratori kugira ngo yigane poroteyine zisanzwe z'umubiri wawe, ariko ifite akazi kadasanzwe: gushaka no kwifatanya na HER2 receptors kuri selile za kanseri.
Uyu muti ukora uhagarika ibimenyetso bibwira selile za kanseri kwiyongera no gukwirakwira. Mu guhagarika ibi bimenyetso byo gukura, pertuzumab ifasha kugabanya cyangwa guhagarika iterambere rya kanseri y'ibere ya HER2-positive.
Pertuzumab ikoreshwa by'umwihariko mu kuvura kanseri y'ibere ya HER2-positive mu bantu bakuru. Ibi bivuze ko selile zawe za kanseri zifite poroteyine nyinshi za HER2, bituma zikura vuba kurusha selile zisanzwe z'ibere.
Muganga wawe azakoresha uyu muti hamwe n'indi miti ya kanseri, akenshi trastuzumab na chemotherapy. Bikoreshwa gake wenyine kuko ubuvuzi buhuriweho bukunda kugira akamaro kurwanya ubwoko bwa kanseri bukaze.
Uyu muti wemerejwe mu byiciro bitandukanye bya kanseri y'ibere ya HER2-positive. Ibi birimo kanseri y'ibere yo mu ntangiriro mbere yo kubagwa, kanseri y'ibere yateye imbere, n'ibibazo aho kanseri yakwiriye mu bindi bice by'umubiri wawe.
Pertuzumab ikora ibyo ikingira inzira ya poroteyine ya HER2 selile za kanseri zikoresha kugira ngo zikure kandi zigabanyemo. Ifatwa nk'ubuvuzi bwibanze bwo hagati bukomeye bwibasira by'umwihariko selile za kanseri mugihe zisiga selile nyinshi zifite ubuzima bwiza.
Uyu muti wifatanya n'igice gitandukanye cya poroteyine ya HER2 kurusha ibindi byinshi bisa nawo nka trastuzumab. Ubu buryo bwo guhagarika kabiri butuma selile za kanseri zigora kubona uburyo bwo gukomeza gukura.
Iyo pertuzumab yifatanije kuri poroteyine za HER2, irinda selile za kanseri kwakira ibimenyetso bya
Ku kanseri y'ibere yo mu ntangiriro, imiti isanzwe imara umwaka umwe, harimo n'igihe mbere na nyuma yo kubagwa. Ku kanseri y'ibere yateye imbere cyangwa yimukiye ahandi, imiti ishobora gukomeza igihe umuti ukora neza kandi ukaba wihanganirwa.
Muganga wawe azajya akurikirana buri gihe uko imiti ikora neza binyuze mu igeragezwa ry'amaraso, isesengura ry'amashusho, n'ibizamini by'umubiri. Bazahindura gahunda yawe y'imiti bitewe n'uko kanseri yawe yitwara n'uko wumva umeze muri rusange.
Kimwe n'indi miti yose ya kanseri, pertuzumab ishobora gutera ingaruka, nubwo atari buri wese uzazigira. Ingaruka nyinshi zishobora guhangana nazo hakoreshejwe ubuvuzi bukwiye n'inkunga.
Dore ingaruka zisanzwe ushobora guhura nazo, kandi ni ngombwa kwibuka ko ikipe yawe y'ubuvuzi yiteguye kugufasha guhangana n'izo ari zo zose:
Ikipe yawe y'ubuvuzi izagukurikiranira hafi izo ngaruka kandi itange imiti cyangwa uburyo bwo gufasha kuzihangana. Abantu benshi basanga ingaruka ziba zoroshye uko umubiri wabo wimenyereza imiti.
Hariho kandi n'izindi ngaruka zitari nyinshi ariko zikomeye cyane, ikipe yawe y'ubuvuzi izazitaho cyane. Izi zisaba ubuvuzi bwihutirwa, ariko ni gake zibaho:
Pertuzumab ntikwiriye buri wese, kandi umuganga wawe azasuzuma neza amateka yawe y'ubuzima mbere yo gutangira kuvurwa. Uyu muti ukoreshwa gusa ku kanseri y'ibere ya HER2-positive, bityo ntuzandikwa niba kanseri yawe itagira iyi poroteyine yihariye.
Ntabwo ushobora kuba umukandida wa pertuzumab niba ufite ibibazo bikomeye by'umutima. Uyu muti ushobora kugira ingaruka ku mikorere y'umutima, bityo umuganga wawe azakora ibizamini by'umutima mbere yo gutangira kuvurwa kugira ngo yemeze ko bikwiriye kuri wowe.
Niba utwite cyangwa ufite gahunda yo gutwita, pertuzumab ntisabwa kuko ishobora gukomeretsa umwana utaravuka. Umuganga wawe azaganira ku buryo bwo kuboneza urubyaro bwiza niba uri mu gihe cyo kubyara.
Abantu bafite ibibazo bikomeye by'impyiko cyangwa umwijima bashobora gukenera guhindura urugero rw'umuti cyangwa ntibashobore gufata uyu muti. Umuganga wawe azakora ibizamini by'amaraso kugira ngo arebe imikorere y'ingingo zawe mbere yo gutangira kuvurwa.
Izina ry'ubwoko bwa pertuzumab ni Perjeta, ikorwa na Genentech. Iri niryo zina ryonyine ry'ubwoko bw'uyu muti wihariye muri Leta Zunze Ubumwe z'Amerika.
Kugeza ubu, nta bwoko bwa pertuzumab buhari. Kubera ko uyu ari umuti ugoye, bifata igihe kirekire kugira ngo ubwoko bwawo bukorerwe kandi bwemezwe ugereranije n'ibinini bisanzwe.
Ikigo cyawe cy'ubwishingizi n'ikipe yawe y'ubuzima bazakorana kugira ngo bagufashe kubona uyu muti, kuko ufatwa nk'ubuvuzi busanzwe bwa kanseri y'ibere ya HER2-positive.
Mugihe pertuzumab akenshi ifatwa nk'urugero rwiza rwo kuvura kanseri y'ibere ya HER2-positive, hariho n'izindi nzira z'ubuvuzi zigenewe. Ariko, ibi ntibisobanura ko ari ibisimbura byose, kuko ubuvuzi buhuriweho akenshi bufite akamaro kanini.
Trastuzumab (Herceptin) ni undi muti ugamije HER2 ukoreshwa akenshi hamwe na pertuzumab. Abantu bamwe bashobora guhabwa trastuzumab bonyine cyangwa bahujwe n'indi miti niba pertuzumab itabakwiriye.
Imiti mishya nka trastuzumab deruxtecan (Enhertu) cyangwa tucatinib (Tukysa) ishobora kuba inzira zatoranijwe mu bihe bimwe na bimwe, cyane cyane niba kanseri yarateye imbere ku zindi nshuti. Muganga wawe w'inzobere mu by'ubuvuzi azagena uburyo bwiza bwo kuvura bushingiye ku miterere yawe yihariye.
Pertuzumab na trastuzumab bikora neza iyo bikoreshejwe hamwe kuruta uko umuti umwe ukoreshwa wenyine. Ntabwo ari imiti irushanwa ahubwo ni ubuvuzi bwuzuzanya bugamije ibice bitandukanye by'inzira imwe ya poroteyine ya HER2.
Ubushakashatsi bwagaragaje ko gukoresha pertuzumab hamwe na trastuzumab byongera ibisubizo ugereranije no gukoresha trastuzumab wenyine. Ubu buryo buhuriweho bwahindutse urugero rw'ubuvuzi ku bantu benshi bafite kanseri y'ibere ya HER2-positive.
Muganga wawe ashobora gushyira mu bikorwa imiti yombi hamwe na chimiothérapie, kuko uru ruhurirane rugaragaza ibisubizo byiza mu igeragezwa ryo kwa muganga. Icyemezo ntigishingiye ku guhitamo kimwe mu kindi, ahubwo gishingiye ku kubikoresha hamwe mu buryo bwiza.
Pertuzumab ishobora kugira ingaruka ku mikorere y'umutima, bityo abantu bafite ibibazo by'umutima basanzwe bakeneye gukurikiranwa by'umwihariko. Muganga wawe azakora ibizamini by'imikorere y'umutima mbere yo gutangira kuvurwa kandi buri gihe mu gihe cy'ubuvuzi bwawe.
Niba ufite ibibazo byoroheje by'umutima, ushobora gukomeza guhabwa pertuzumab hamwe no gukurikiranwa hafi kw'umutima. Ariko, niba ufite urugero rwo hejuru rwo kunanirwa k'umutima cyangwa izindi ndwara zikomeye z'umutima, muganga wawe ashobora kugusaba izindi miti.
Inkuru nziza ni uko ingaruka zifitanye isano n'umutima akenshi zishobora gukira niba zamenyekanye hakiri kare. Itsinda ryawe ry'abaganga rizakurikirana imikorere y'umutima wawe neza kandi rishobora guhindura cyangwa guhagarika imiti niba bibaye ngombwa.
Kubera ko pertuzumab ihabwa buri gihe ahantu havurirwa n'abantu babihuguriwe, kwirenza urugero ry'umuti bitunguranye ni gake cyane. Uyu muti ubara neza ukurikije uburemere bw'umubiri wawe kandi utangwa unyuze mu muyoboro wa IV ugendeshwa mu buryo bugenzurwa.
Niba ufite impungenge ku rugero rwawe cyangwa ubona ibimenyetso bidasanzwe mugihe cyangwa nyuma yo kuvurwa, bimenyeshe itsinda ryawe ry'ubuzima ako kanya. Bashobora kugukurikirana neza kandi bagatanga ubufasha niba bibaye ngombwa.
Itsinda ryawe ry'abaganga rifite gahunda zo gukumira amakosa yo gutanga imiti, harimo gusubiramo imibare no gukoresha sisitemu z'umutekano mu gutanga imiti ya IV.
Niba wasibye gahunda ya pertuzumab, vugana n'itsinda ryawe ryo kuvura kanseri vuba bishoboka kugirango wongere utegure gahunda. Bazagena uburyo bwiza bwo kukugarura mu nzira hamwe na gahunda yawe yo kuvurwa.
Kusiba urugero rumwe akenshi ntizagira ingaruka zikomeye ku kuvurwa kwawe, ariko ni ngombwa gukurikiza gahunda yawe isanzwe igihe bibaye ngombwa. Muganga wawe ashobora guhindura gato igihe cyo kuvurwa kwawe kugirango akire urugero rwasibwe.
Ntugerageze gusubiza urugero rwasibwe utegura imiti yegereye hamwe. Umubiri wawe ukeneye igihe hagati y'urugero kugirango ukire kandi usubize neza imiti.
Ugomba guhagarika gusa imiti ya pertuzumab uyobowe na muganga wawe. Umwanzuro wo guhagarika biterwa n'ibintu bitandukanye, harimo uko kanseri yawe yitwara neza n'ingaruka zikubaho.
Ku kanseri y'ibere yo mu ntangiriro, imiti isanzwe ifite itariki yo kurangira nyuma y'umwaka umwe. Ku kanseri yateye imbere, imiti irashobora gukomeza igihe cyose ikora kandi uyihanganira neza.
Muganga wawe azajya asuzuma buri gihe niba gukomeza imiti bikugirira akamaro. Bazatekereza ibintu nk'uko kanseri ikomeza, ingaruka zikubaho, n'imibereho yawe muri rusange mugihe bafata uyu mwanzuro.
Abantu benshi barashobora gukomeza gukora mugihe bakoresha imiti ya pertuzumab, nubwo ushobora gukenera guhindura gahunda yawe hakurikijwe amateraniro yo guterwa imiti no gucunga umunaniro cyangwa izindi ngaruka.
Amateraniro yo guterwa imiti asanzwe afata amasaha make buri byumweru bitatu, bityo uzakenera gutegura igihe cyo kuva ku kazi kubera aya materaniro. Abantu bamwe barumva bananiwe umunsi umwe cyangwa ibiri nyuma yo guterwa imiti, mugihe abandi bumva bameze neza.
Ganira n'umukoresha wawe kubyerekeye gahunda y'akazi yoroshye niba bikenewe. Abantu benshi basanga bashobora gukomeza ibikorwa byabo bisanzwe hamwe n'impinduka zimwe mugihe bakoresha imiti.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.